Regulation of retinoic acid receptor β expression by peroxisome proliferator-activated receptor γ ligands in cancer cells

Cancer Research

Volumn 63, Issue 13, 2003, Pages 3531-3538

  James, Sharon Y ^a   Lin, Feng ^a   Kolluri, Siva Kumar ^a   Dawson, Marcia I ^a   Zhang, Xiao Kun ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1,3 DIOXOLAN 2 YL]BENZOIC ACID; CIGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; RETINOID X RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING;

APOPTOSIS; BENZOATES; BREAST NEOPLASMS; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; LUNG NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RETINOIDS; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0038418393     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. The nuclear receptor superfamily: the second decade. Cell, 83: 835-839, 1995.
2. Moller, D. E., and Berger, J. The mechanisms of action of PPARs. Annu. Rev. Med., 53: 409-435, 2002.
3. Rosen, E. D., Walkey, C. J., Puigserver, P., and Spiegelman, B. M. Transcriptional regulation of adipogenesis. Genes Dev., 14: 1293-1307, 2000.
4. Rangwala, S. M., and Lazar, M. A. Transcriptional control of adipogenesis. Annu. Rev. Nutr., 20: 535-559, 2000.
5. Rosen, E. D., and Spiegelman, B. M. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem., 276: 37731-37734, 2001.
6. Hihi, A. K., Michalik, L., and Wahli, W. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci., 59: 790-798, 2002.
7. Sporn, M. B., Suh, N., and Mangelsdorf, D. J. Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs). Trends Mol. Med., 7: 395-400, 2001.
8. Kersten, S., Desvergne, B., and Wahli, W. Roles of PPARs in health and disease. Nature (Lond.), 405: 421-424, 2000.
9. Murphy, G. J., and Holder, J. C. PPARγ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. Sci., 21: 469-474, 2000.
10. 2-induced apoptosis in breast cancer cells. J. Biol. Chem., 276: 47131-47135, 2001.
11. Kilgore, M. W., Tate, P. L., Rai, S., Sengoku, E., and Price, T. M. MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response. Mol. Cell. Endocrinol., 129: 229-235, 1997.
12. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., and Spiegelman, B. M. Terminal differentiation of human breast cancer through PPARγ. Mol. Cell, 1: 465-470, 1998.
13. Suh, N., Wang, Y., Williams, C. R., Risingsong, R., Gilmer, T., Willson, T. M., and Sporn, M. B. A new ligand for the peroxisome proliferator-activated receptor γ (PPARγ). GW7845, inhibits rat mammary carcinogenesis. Cancer Res., 59: 5671-5673, 1999.
14. Pignatelli, M., Cortes-Canteli, M., Lai, C., Santos, A., and Perez-Castillo, A. The peroxisome proliferator-activated receptor γ is an inhibitor of ErbBs activity in human breast cancer cells. J. Cell Sci., 114: 4117-4126, 2001.
15. Thoennes, S. R., Tate, P. L., Price, T. M., and Kilgore, M. W. Differential transcriptional activation of peroxisome proliferator-activated receptor γ by ω-3 and ω-6 fatty acids in MCF-7 cells. Mol. Cell. Endocrinol., 160: 67-73, 2000.
16. I cell cycle regulators. Biochem. Biophys. Res. Commun., 286: 916-922, 2001.
17. Elstner, E., Muller, C., Koshizuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D., and Koeffler, H. P. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA, 95: 8806-8811, 1998.
18. Mehta, R. G., Williamson, E., Patel, M. K., and Koeffler, H. P. A ligand of peroxisome proliferator-activated receptor γ, retinoids, and prevention of preneoplastic mammary lesions. J. Natl. Cancer Inst. (Bethesda), 92: 418-423, 2000.
19. Theocharis, S., Kanelli, H., Politi, E., Margeli, A., Karkandaris, C., Philippides, T., and Koutselinis. A. Expression of peroxisome proliferator activated receptor γ in non-small cell lung carcinoma: correlation with histological type and grade. Lung Cancer, 36: 249-255, 2002.
20. Satoh, T., Toyoda, M., Hoshino, H., Monden, T., Yamada, M., Shimizu, H., Miyamoto, K., and Mori, M. Activation of peroxisome proliferator-activated receptor γ stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Oncogene, 21: 2171-2180, 2002.
21. Tsubouchi, Y., Sano, H., Kawahito, Y., Mukai, S., Yamada, R., Kohno, M., Inoue, K., Hla, T., and Kondo, M. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor γ agonists through induction of apoptosis. Biochem. Biophys. Res. Commun., 270: 400-405, 2000.
22. Chang, T. H., and Szabo, E. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer. Cancer Res., 60: 1129-1138, 2000.
23. Lippman, S. M., and Lotan, R. Advances in the development of retinoids as chemopreventive agents. J. Nutr., 130: 479S-482S, 2000.
24. Altucci, L., and Gronemeyer, H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer, 1: 181-193, 2001.
25. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 10: 940-954, 1996.
26. Zhang, X. K., Hoffmann, B., Tran, P. B., Graupner, G., and Pfahl, M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature (Lond.), 355: 441-446, 1992.
27. Nunez, S. B., Medin, J. A., Braissant, O., Kemp, L., Wahli, W., Ozato, K., and Segars, J. H. Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor. Mol. Cell. Endocrinol., 127: 27-40, 1997.
28. Stoll, B. A. Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention. Eur. J. Cancer Prev., 11: 319-325, 2002.
29. Zhang, X. K. Vitamin A and apoptosis in prostate cancer. Endocr. Relat. Cancer, 9: 87-102, 2002.
30. Zhang, X. K., Liu, Y., and Lee, M. O. Retinoid receptors in human lung cancer and breast cancer. Mutat. Res., 350: 267-277, 1996.
31. Gebert, J. F., Moghal, N., Frangioni, J. V., Sugarbaker, D. J., and Neel, B. G. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene, 6: 1859-1868, 1991.
32. Houle, B., Leduc, F., and Bradley, W. E. Implication of RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer, 3: 358-366, 1991.
33. Hu, L., Crowe, D. L., Rheinwald, J. G., Chambon, P., and Gudas, L. J. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res., 51: 3972-3981, 1991.
34. Nervi, C., Vollberg, T. M., George, M. D., Zelent, A., Chambon, P., and Jetten, A. M. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp. Cell Res., 195: 163-170, 1991.
35. Liu, Y., Lee, M. O., Wang, H. G., Li, Y., Hashimoto, Y., Klaus, M., Reed, J. C., and Zhang, X. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol., 16: 1138-1149, 1996.
36. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ., 5: 133-141, 1994.
37. 2 transgene. FASEB J., 10: 1091-1097, 1996.
38. Lotan, R., Xu, X. C., Lippman, S. M., Ro, J. Y., Lee, J. S., Lee, J. J., and Hong, W. K. Suppression of retinoic acid receptor β in premalignant oral lesions and its upregulation by isotretinoin. N. Engl. J. Med., 332: 1405-1410, 1995.
39. Wu, Q., Dawson, M. I., Zheng, Y., Hobbs, P. D., Agadir, A., Jong, L., Li, Y., Liu, R., Lin, B., and Zhang, X. K. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol. Cell. Biol., 17: 6598-6608, 1997.
40. Lin, B., Chen, G. Q., Xiao, D., Kolluri, S. K., Cao, X., Su, H., and Zhang, X. K. Orphan receptor COUP-TF is required for induction of retinoic acid receptor β, growth inhibition, and apoptosis by retinoic acid in cancer cells. Mol. Cell. Biol., 20: 957-970, 2000.
41. Bovenzi, V., and Momparler, R. L. Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor a genes in breast carcinoma cells. Cancer Chemother. Pharmacol., 48: 71-76, 2001.
42. Sirchia, S. M., Ferguson, A. T., Sironi, E., Subramanyan, S., Orlandi, R., Sukumar, S., and Sacchi, N. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells. Oncogene, 19: 1556-1563, 2000.
43. Widschwendter, M., Berger, J., Hermann, M., Muller, H. M., Amberger, A., Zeschnigk, M., Widschwendter, A., Abendstein, B., Zeimet, A. G., Daxenbichler, G., and Marth, C. Methylation and silencing of the retinoic acid receptor β2 gene in breast cancer. J. Natl. Cancer Inst. (Bethesda), 92: 826-832, 2000.
44. Sirchia, S. M., Ren, M., Pili, R., Sironi, E., Somenzi, G., Ghidoni, R., Toma, S., Nicolo, G., and Sacchi, N. Endogenous reactivation of the RARβ2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res., 62: 2455-2461, 2002.
45. Momparler, R. L., and Bovenzi, V. DNA methylation and cancer. J. Cell Physiol., 183: 145-154, 2000.
46. Wright, H. M., Clish, C. B., Mikami, T., Hauser, S., Yanagi, K., Hiramatsu, R., Serhan, C. N., and Spiegelman, B. M. A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation. J. Biol. Chem., 275: 1873-1877, 2000.
47. Lehmann, J. M., Jong, L., Fanjul, A., Cameron, J. F., Lu, X. P., Haefner, P., Dawson, M. I., and Pfahl, M. Retinoids selective for retinoid X receptor response pathways. Science (Wash. DC), 258: 1944-1946, 1992.
48. Dawson, M. I., Jong, L., Hobbs, P. D., Cameron, J. F., Chao, W. R., Pfahl, M., Lee, M. O., Shroot, B., and Pfahl, M. Conformational effects of retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J. Med. Chem., 38: 3368-3383, 1995.
49. Dawson, M. I., Hobbs, P. D., Jong, L., Xiao, D., Chao, W. R., Pan, C., and Zhang, X. K. sp2-bridged diaryl retinoids: effects of bridge-region substitution on retinoid X receptor selectivity. Bioorg. Med. Chem. Lett., 10: 1307-1310, 2000.
50. Hoffmann. B., Lehmann, J. M., Zhang, X. K., Hermann, T., Husmann, M., Graupner, G., and Pfahl, M. A retinoic acid receptor-specific element controls the retinoic acid receptor-β promoter. Mol. Endocrinol., 4: 1727-1736, 1990.
51. James, S. Y., Mercer, E., Brady, M., Binderup, L., and Colston, K. W. EB 1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br. J. Pharmacol., 125: 953-962, 1998.
52. Mangelsdorf, D. J., and Evans, R. M. The RXR heterodimers and orphan receptors. Cell, 83: 841-850, 1995.
53. Li, Y., Dawson, M. I., Agadir, A., Lee, M. O., Jong, L., Hobbs, P. D., and Zhang. X. K. Regulation of RARβ expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction. Int. J. Cancer, 75: 88-95, 1998.
54. Sucov, H. M., Murakami, K. K., and Evans, R. M. Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene. Proc. Natl. Acad. Sci. USA, 87: 5392-5396, 1990.
55. Fontana, J. A., Hobbs, P. D., and Dawson, M. I. Inhibition of mammary carcinoma growth by retinoidal benzoic acid derivatives. Exp. Cell Biol., 56: 254-263, 1988.
56. van der Burg, B., van der Leede, B. M., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol., 91: 149-157, 1993.
57. Gottardis, M. M., Bischoff, E. D., Shirley, M. A., Wagoner, M. A., Lamph, W. W., and Heyman, R. A. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand. Cancer Res., 56: 5566-5570, 1996.
58. Bischoff, E. D., Gottardis, M. M., Moon, T. E., Heyman, R. A., and Lamph, W. W. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma. Cancer Res., 58: 479-484, 1998.
59. Mukherjee, R., Davies, P. J., Crombie, D. L., Bischoff, E. D., Cesario, R. M., Jow, L., Hamann, L. G., Boehm, M. F., Mondon, C. E., Nadzan, A. M., Paterniti, J. R., Jr., and Heyman, R. A. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature (Lond.), 386: 407-410, 1997.
60. Chen, G. Q., Lin, B., Dawson, M. I., and Zhang, X. K. Nicotine modulates the effects of retinoids on growth inhibition and RARβ expression in lung cancer cells. Int. J. Cancer, 99: 171-178, 2002.
61. Kim, Y. H., Dohi, D. F., Han, G. R., Zou, C. P., Oridate, N., Walsh, G. L., Nesbitt, J. C., Xu, X. C., Hong, W. K., Lotan, R., et al. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res., 55: 5603-5610, 1995.
62. Zhang, X. K., Liu, Y., Lee, M. O., and Pfahl, M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res., 54: 5663-5669, 1994.
63. van der Leede, B. M., van den Brink, C. E., and van der Saag, P. T. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines. Mol. Carcinog., 8: 112-122, 1993.
64. Moghal, N., and Neel, B. G. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol. Cell. Biol., 15: 3945-3959, 1995.
65. Kurokawa, R., DiRenzo, J., Boehm, M., Sugarman, J., Gloss, B., Rosenfeld, M. G., Heyman, R. A., and Glass, C. K. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature (Lond.), 371: 528-531, 1994.
66. Zechel, C., Shen, X. Q., Chen, J. Y., Chen, Z. P., Chambon, P., and Gronemeyer, H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J., 13: 1425-1433, 1994.
67. IJpenberg, A., Jeannin, E., Wahli, W., and Desvergne, B. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. J. Biol. Chem., 272: 20108-20117, 1997.
68. Hsu, M. H., Palmer, C. N., Song, W., Griffin, K. J., and Johnson, E. F. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J. Biol. Chem., 273: 27988-27997, 1998.